Two of the most exciting advances in cancer care - precision medicine and immunotherapy - are improving outcomes, reducing side effects and offering new hope for patients and families. Join Henry Tsai, MD, Board Certified Medical Oncologist, and Shu Mei Kato, MD, Board Certified Medical Oncologist, for this engaging and informative discussion for anyone interested in better understanding the latest breakthroughs in personalized cancer care. Learn how doctors are using genetic and molecular information to select the most effective treatments and how immunotherapy is harnessing the power of the body's own immune system to fight cancer.
Presented as part of the Selby Dunham Community Lecture Series